These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 15467578)

  • 1. Morbidity that is associated with curettage for the management of spontaneous and induced abortion in women who are infected with HIV.
    Stuart GS; Sheffield JS; Hill JB; McIntire DD; McElwee B; Wendel GD
    Am J Obstet Gynecol; 2004 Sep; 191(3):993-7. PubMed ID: 15467578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors associated with immediate abortion complications.
    Ferris LE; McMain-Klein M; Colodny N; Fellows GF; Lamont J
    CMAJ; 1996 Jun; 154(11):1677-85. PubMed ID: 8646655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of pregnancy on maternal AIDS.
    Kumar RM; Uduman SA; Khurrana AK
    J Reprod Med; 1997 Jul; 42(7):429-34. PubMed ID: 9252934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of ICSI in HIV-1-infected women.
    Terriou P; Auquier P; Chabert-Orsini V; Chinchole JM; Cravello L; Giorgetti C; Halfon P; Salzmann J; Roulier R
    Hum Reprod; 2005 Oct; 20(10):2838-43. PubMed ID: 15980007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is induced abortion with misoprostol a risk factor for late abortion or preterm delivery in subsequent pregnancies?
    Winer N; Resche-Rigon M; Morin C; Ville Y; Rozenberg P
    Eur J Obstet Gynecol Reprod Biol; 2009 Jul; 145(1):53-6. PubMed ID: 19427095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis B and C in pregnant women who are infected with human immunodeficiency virus.
    Santiago-Munoz P; Roberts S; Sheffield J; McElwee B; Wendel GD
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1270-3. PubMed ID: 16157150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rates of postoperative complications among human immunodeficiency virus-infected women who have undergone obstetric and gynecologic surgical procedures.
    Grubert TA; Reindell D; Kästner R; Belohradsky BH; Gürtler L; Stauber M; Dathe O
    Clin Infect Dis; 2002 Mar; 34(6):822-30. PubMed ID: 11850864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trends in induced abortion during the 12 years since legalization in Norway.
    Skjeldestad FE; Borgan JK
    Fam Plann Perspect; 1994; 26(2):73-6. PubMed ID: 8033981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manual versus electric vacuum aspiration for early first-trimester abortion: a controlled study of complication rates.
    Goldberg AB; Dean G; Kang MS; Youssof S; Darney PD
    Obstet Gynecol; 2004 Jan; 103(1):101-7. PubMed ID: 14704252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of human immunodeficiency virus infection and drug use on birth characteristics.
    Johnstone FD; Raab GM; Hamilton BA
    Obstet Gynecol; 1996 Sep; 88(3):321-6. PubMed ID: 8752232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased peri- and post-elective cesarean section morbidity in women infected with human immunodeficiency virus-1: a case-controlled multicenter study.
    Lapaire O; Irion O; Koch-Holch A; Holzgreve W; Rudin C; Hoesli I;
    Arch Gynecol Obstet; 2006 Jun; 274(3):165-9. PubMed ID: 16715290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications according to mode of delivery among human immunodeficiency virus-infected women with CD4 lymphocyte counts of < or = 500/microL.
    Watts DH; Lambert JS; Stiehm ER; Bethel J; Whitehouse J; Fowler MG; Read J
    Am J Obstet Gynecol; 2000 Jul; 183(1):100-7. PubMed ID: 10920316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative morbidity associated with cesarean delivery among human immunodeficiency virus-seropositive women.
    Rodriguez EJ; Spann C; Jamieson D; Lindsay M
    Am J Obstet Gynecol; 2001 May; 184(6):1108-11. PubMed ID: 11349171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in induced legal abortion morbidity and mortality.
    Binkin NJ
    Clin Obstet Gynaecol; 1986 Mar; 13(1):83-93. PubMed ID: 3709015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pregnancy outcome in women infected with the human immunodeficiency virus].
    Figueroa-Damián R
    Salud Publica Mex; 1999; 41(5):362-7. PubMed ID: 11142830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curettage vs. nonsurgical management in women with early spontaneous abortions. The effect on fertility.
    Ben-Baruch G; Schiff E; Moran O; Menashe Y; Mashiach S; Menczer J
    J Reprod Med; 1991 Sep; 36(9):644-6. PubMed ID: 1774726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A six month prospective study on different aspects of abortion.
    Madebo T; G/Tsadic T
    Ethiop Med J; 1993 Jul; 31(3):165-72. PubMed ID: 8404881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pregnancy and labor after spontaneous and induced abortion].
    Krasnodebski J; Rajda M; Potepa M; Piechowicz A
    Przegl Lek; 1989; 46(4):385-90. PubMed ID: 2788897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of pregnancy to human papillomavirus among human immunodeficiency virus-infected women.
    Minkoff H; Shen X; Watts DH; Leighty R; Hershow R; Palefsky J; Tuomala R; Neu N; Zorrilla CD; Paul M; Strickler H
    Obstet Gynecol; 2006 Oct; 108(4):953-60. PubMed ID: 17012459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curettage after midtrimester termination of pregnancy. Is it necessary?
    Lurie S; Appelman Z; Katz Z
    J Reprod Med; 1991 Nov; 36(11):786-8. PubMed ID: 1765956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.